UnitedHealth Group Incorporated $UNH Shares Acquired by IFM Investors Pty Ltd

IFM Investors Pty Ltd raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 175,277 shares of the healthcare conglomerate’s stock after purchasing an additional 346 shares during the period. UnitedHealth Group accounts for approximately 1.0% of IFM Investors Pty Ltd’s investment portfolio, making the stock its 15th biggest holding. IFM Investors Pty Ltd’s holdings in UnitedHealth Group were worth $91,801,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in UNH. Bayforest Capital Ltd increased its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd increased its position in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the period. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $42,000. Copia Wealth Management acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $42,000. Finally, O Brien Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after buying an additional 37 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. Deutsche Bank Aktiengesellschaft dropped their target price on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a report on Wednesday, May 14th. Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research note on Friday, September 5th. Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Oppenheimer lowered their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $355.77.

UnitedHealth Group Price Performance

NYSE:UNH opened at $348.59 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The stock has a 50 day moving average of $289.41 and a two-hundred day moving average of $371.39. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market cap of $315.71 billion, a P/E ratio of 15.10, a price-to-earnings-growth ratio of 2.09 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter last year, the firm posted $6.80 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.